NL
DE
René Marke, PhD candidate at the Laboratory of Pediatric Oncology, theme Cancer development and immune defense, has received the Tom Voûte Young Investigator Award 2017. This price is handed out each year bij Kika (kinderen kankervrij) for excellent research in the area of pediatric oncology.
As part of his thesis work in the group of Frank van Leeuwen, René has been studying role of the lymphoid transcription factor IKZF1 in glucocorticoid therapy resistance in Acute Lymphoblastic Leukemia (ALL). Rene found that loss of IKZF1 function in ALL contributes to glucocorticoid resistance in the patient, which may explain why patients carrying this deletion have a less favorable prognosis. His current research focuses on the mechanisms by which IKZF1 loss leads to glucocorticoid resistance, and the identification of molecular therapies that can improve therapy response is this high risk ALL subgroup.
The jury was impressed by the scientific quality of the work, which was presented by René on 28 September at the annual KiKa science day organized by the Prinses Maxima Center for Pediatric Oncology.
Tom Voûte Young Investigator Award 2017: link
Related news items
T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read more
A single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read more
Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more
European grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more
Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation published in Cellular and Molecular Life Sciences
20 April 2022 Lisa Huis in ‘t Veld, Nataschja Ho and colleagues from the team of Gosse Adema published in Cellular and Molecular Life Sciences that Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation. read more
